Generics [UK] Limited

introduction

	From modest beginnings in 1981, Generics [UK] Limited has grown from a small "family" business to a leading UK generic pharmaceutical manufacturer and distributor, with products encompassing all the major therapeutic classes.

	Formerly part of the Merck Generics Group, which first consolidated in 1989 and acquired by Merck KGaA in 1994. On October 2nd 2007, Mylan acquired the Generics Group which comprises a number of companies, including:

Mylan is a global pharmacuetical company with market leading positions in generic pharmaceuticals, transdermal technology and unit dose packaged products. They focus on providing an extensive line of affordable, high quality prescription drugs in traditional and innovative dosage forms, and enjoy a well-deserved repution for scientific expertise in creating dificult-to-formulate and high-barrier-to-entry generic products.
The new Mylan now offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries.

	Alphapharm, Australia
	Merck Generics, Belgium
	Genpharm, Canada
	Gerard Laboratories, Eire
	Merck Génériques , France
	Merck Dura , Germany
	Merck Generics, Italy
	Merck Generics, Netherlands
	Merck Generics, South Africa
	Merck Generics, Spain
	Scandpharm Generics , Sweden
	Dey, USA